Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · November 14, 2021

Inhaled Corticosteroid Dose is Associated With Pseudomonas aeruginosa Infection in Severe COPD

BMJ Open Respiratory Research


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ Open Respiratory Research
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
BMJ Open Respir Res 2021 Oct 01;8(1)1, H Shafiek, J Verdú, A Iglesias, L Ramon-Clar, N Toledo-Pons, C Lopez-Causape, C Juan, P Fraile-Ribot, A Oliver, BG Cosio

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading